~~<i id='68E0269ADE'><strike id='68E0269ADE'><tt id='68E0269ADE'><pre id='68E0269ADE'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

focus

author：fashion 2025-09-29 17:02:40 - browse：8766

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Gilead might be held responsible for not developing a drug

knowledge

Wikipedia

entertainment

Wikipedia

hotspot

ChrisO'Meara/APJohnson&Johnsonfacesaconsequentialnewclassactionlawsuit—notinitsroleasamanuf

WSS

Medicare Advantage proposed rates disappoint insurers

Surgery pushed Ben Carson to fame

340B reform proposal comes out of Senate working group

A disappointing year of Humira biosimilars

Cano Health’s bankruptcy is a warning for Medicare Advantage

Devoted Health’s losses in Medicare Advantage persist

knowledge

focus

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

A disappointing year of Humira biosimilars

The high cost of giving birth even with insurance

Industry veterans launch new biotech VC with $310M

Malaria cases in Florida and Texas: Here’s what you need to know

BioAge raises $170M for combination therapy with Zepbound

Hollywood unions extend contract negotiations for actors

The Biogen Aduhelm mess could happen again

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Wikipedia

Unique patient identifier: Experts argue the benefits, pitfalls

Medical mystery: When a cough is not just a cough

The CDC's new social media misinformation war

Gilead might be held responsible for not developing a drug

Surgery pushed Ben Carson to fame

KalVista pill reduced swelling 'attacks' caused by genetic disease

Wikipedia

entertainment

Wikipedia

hotspot